rs622342

Orientation

plus

Stabilized

plus

Geno	Mag	Summary
(A;A)	0
(C;C)	2	influences dosage for Parkinson's patients

Make rs622342(A;C)

Reference

GRCh38 38.1/141

Chromosome

6

Position

160151834

Gene

SLC22A1

is a	snp
is	mentioned by
dbSNP	rs622342
dbSNP (classic)	rs622342
ClinGen	rs622342
ebi	rs622342
HLI	rs622342
Exac	rs622342
Gnomad	rs622342
Varsome	rs622342
LitVar	rs622342
Map	rs622342
PheGenI	rs622342
Biobank	rs622342
1000 genomes	rs622342
hgdp	rs622342
ensembl	rs622342
geneview	rs622342
scholar	rs622342
google	rs622342
pharmgkb	rs622342
gwascentral	rs622342
openSNP	rs622342
23andMe	rs622342
SNPshot	rs622342
SNPdbe	rs622342
MSV3d	rs622342
GWAS Ctlg	rs622342

GMAF

0.2713

Max Magnitude

2

?	(A;A) (A;C) (C;C)	28

[PMID 19381165] Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

[PMID 19898263] Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response

[PMID 20680652] OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users

[PMID 21241070] Clinical pharmacokinetics of metformin

[PMID 22882994] Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes.

[PMID 23612856] Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients.

[PMID 25398212] Genetic polymorphisms of the organic cation transporter 1 gene (SLC22A1) within the Cape Admixed population of South Africa

[PMID 25492374] Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patients